Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GSK launches larger 204-lozenge packs of Nicotinell

Smoking cessation brand Nicotinell is launching a larger pack of its nicotine lozenges.

The lozenges – now available in packs of 204 – can be purchased in nicotine strengths of 1mg or 2mg across “icemint”, mint, fruit, and liquorice flavours, manufacturer GlaxoSmithKline said.

“Light smokers” should use the 1mg strength, while patients smoking 20-30 cigarettes a day should purchase 2mg, it recommended.

Their launch will be supported by an online campaign, including display banners, and videos on social media featuring stories of smoking quitters, the manufacturer added.

“This launch offers shoppers more choice,” said Nicotinell senior brand manager Jingxuan Zhuang. “Pharmacists continue to play a crucial role in advising shoppers about nicotine replacement therapy.”

A pack of 204 1mg-strength lozenges retails for £20.00, while 2mg is £23.40.

To order Nicotinell products, contact [email protected].

What is the best way to help patients to quit smoking?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD009173

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel